INS and diabetes mellitus: It was mentioned above that in the treatment of diabetes, PPARy agonists can be used, mainly thiazolidinediones (TZD), whose task is to prevent the effects of diabetes by increasing patients’ sensitivity to insulin, leading to a reduction in the concentration of both glucose and insulin in the plasma.